Research Consortium member David Holtzman featured in US News and World Report

A US News and World Report article profiles a new test to determine the effectiveness of Alzheimer's drugs developed by Cure Alzheimer's Fund's Dr. David Holtzman. The stable isotope-linked kinetics or SILK test quickly reveals whether medication is working to limit the harmful protein amyloid beta.

Click here to read full article

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.